Limb-girdle muscular dystrophy type 2A
Alternate names
LGMD2A; Calpainopathy; Limb-girdle muscular dystrophy type 2; LGMD2; Muscular dystrophy, pelvofemoral; Leyden-Moebius muscular dystrophy
Definition
Limb-girdle muscular dystrophy type 2A (LGMD2A) is an autosomal recessive limb-girdle muscular dystrophy characterized by progressive, symmetrical weakness of the proximal limb and girdle muscles (mainly those around the hips and shoulders) without heart involvement or intellectual disability.
Epidemiology
Type 2A is the most common form of limb-girdle muscular dystrophy, accounting for about 30 percent of cases.
Cause
The condition is caused by mutations in the CAPN3 gene.
Types
There are three subtypes of autosomal recessive disorders associated with mutations in the CAPN3 gene which differ by the distribution of muscle weakness and age at onset:
- Pelvifemoral limb-girdle muscular dystrophy (also known as Leyden-Mobius LGMD) is the most frequently observed subtype. In these cases, muscle weakness is first evident in the pelvic girdle and later in the shoulder girdle. Onset is usually before age 12 or after age 30;
- Scapulohumeral LGMD (also known as Erb LGMD) usually has milder symptoms with infrequent early onset. In most cases, muscle weakness is first evident in the shoulder girdle and later in the pelvic girdle;
- HyperCKemia is usually observed in children or young individuals. In most cases, those affected do not have symptoms, just high levels of creatine kinase in their blood.
Signs and symptoms
- Clinical findings of calpainopathy include the tendency to walk on tiptoe, difficulty in running, scapular winging, waddling gait, and slight hyperlordosis.
- Other findings include symmetric weakness of proximal more than distal muscles in the limbs, trunk, and periscapular area; laxity of the abdominal muscles; Achilles tendon shortening; scoliosis; and joint contractures.[1][1].
- Affected individuals typically do not have cardiac involvement or intellectual disability.
Clinical presentation
For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed.
80%-99% of people have these symptoms
- Generalized muscle weakness
30%-79% of people have these symptoms
- Ankle flexion contracture
- Calf muscle hypertrophy(Increased size of calf muscles)
- Congenital finger flexion contractures
- Difficulty walking(Difficulty in walking)
- Elbow flexion contracture(Contractures of elbows)
- Elevated serum creatine kinase(Elevated blood creatine phosphokinase)
- Hamstring contractures
- Hyperlordosis(Prominent swayback)
- Lower limb muscle weakness(Lower extremity weakness)
- Muscular dystrophy
- Pectoralis amyotrophy(Wasting of pec muscles)
- Pelvic girdle amyotrophy
- Proximal muscle weakness(Weakness in muscles of upper arms and upper legs)
- Scapular muscle atrophy
- Scapular winging(Winged shoulder blade)
- Spinal rigidity(Reduced spine movement)
- Toe walking(Toe-walking)
5%-29% of people have these symptoms
- Difficulty climbing stairs(Difficulty walking up stairs)
- Facial palsy(Bell's palsy)
- Wrist flexion contracture
Diagnosis
- The diagnosis of calpainopathy, which is suggested by clinical findings and elevated serum CK concentration, is established by identification of biallelic pathogenic variants in CAPN3 (encoding proteolytic enzyme calpain-3) or a dominantly acting heterozygous pathogenic variant for the CAPN3 21-bp deletion (c.643_663del21) by molecular genetic testing. [2][2].
- If such testing is not available or not conclusive, muscle biopsy with protein immuno-analysis should be used for diagnostic confirmation.
Treatment
- Physical therapy and stretching exercises to promote mobility and prevent contractures
- Aids such as canes, walkers, orthotics, and wheelchairs to help maintain independence
- surgery for foot deformities, scoliosis, and Achilles tendon contractures as needed
- Respiratory aids to treat chronic respiratory insufficiency in late stages of the disease.[3][3].
References
- ↑ Angelini C, Fanin M. Calpainopathy. 2005 May 10 [Updated 2017 Aug 3]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1313/
- ↑ Angelini C, Fanin M. Calpainopathy. 2005 May 10 [Updated 2017 Aug 3]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1313/
- ↑ Angelini C, Fanin M. Calpainopathy. 2005 May 10 [Updated 2017 Aug 3]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK1313/
Muscular dystrophy | ||||||||
---|---|---|---|---|---|---|---|---|
* Category
|
Diseases of muscle, neuromuscular junction, and neuromuscular disease | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Inherited disorders of trafficking / vesicular transport proteins | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
See also vesicular transport proteins
|
Cell membrane protein disorders (other than Cell surface receptor, enzymes, and cytoskeleton) | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
See also other cell membrane proteins
|
NIH genetic and rare disease info
Limb-girdle muscular dystrophy type 2A is a rare disease.
Rare and genetic diseases | ||||||
---|---|---|---|---|---|---|
Rare diseases - Limb-girdle muscular dystrophy type 2A
|
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Deepika vegiraju